PLERIXAFOR
NDC 70771-1776, plerixafor, injection, from Zydus Lifesciences Limited.
- Product NDC
- 70771-1776
- Status
- Listed
- Labeler
- Zydus Lifesciences Limited
- Dosage form
- INJECTION
- Route
- SUBCUTANEOUS
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA208980
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1776 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- PLERIXAFOR24 mg/1.2mL
Pharmacologic classes
Hematopoietic Stem Cell Mobilizer [EPC]; Increased Hematopoietic Stem Cell Mobilization [PE]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 70771-1776-1 | 70771177601 | 1 VIAL, SINGLE-USE in 1 CARTON (70771-1776-1) / 1.2 mL in 1 VIAL, SINGLE-USE |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/43df348a-d7f2-4f14-8131-c916679a98eb
Use it
Look up 70771-1776 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/70771-1776 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 70771-1776. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.